Elimite Patient, Information, Instructions - Permethrin

Elimite Patient, Information, Instructions - Permethrin INFORMATION FOR PATIENTS

Patients with scabies should be advised that itching, mild burning and/or stinging may occur after application of ELIMITE®. In clinical trials approximately 75% of patients treated with ELIMITE® who continued to manifest pruritus at 2 weeks had cessation by 4 weeks. If irritation persists, they should consult their physician. ELIMITE® may be very mildly irritating to the eyes. Patients should be advised to avoid contact with eyes during application and to flush with water immediately if ELIMITE® gets in the eyes.